| Name | Title | Contact Details |
|---|
Activation Laboratories Ltd. is a Ancaster, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Kelcourt Plastics Inc is a San Clemente, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
US Med-Equip is the fastest growing provider of respiratory, neonatal, infusion and other medical devices. We partner with top hospitals across the nation to provide the highest quality movable medical equipment for patients in their care—diagnostic and clinical devices ranging from infusion pumps and patient monitors to ventilators, newborn incubators and more. From major medical centers to underserved rural hospitals, our partners take no chances and count on USME for their medical equipment rental, sales, delivery and service needs, so they can continue to do what they do best: take care of patients in need. Designated as a "Top Workplace," US Med-Equip`s company culture is driven by every employee`s shared purpose: to support the important work healthcare providers do every day to help patients heal. Each team member takes pride in knowing they and their company are doing whatever it takes to help hospitals and medical staff treat patients with the highest quality medical equipment when they need it. As a record number of hospitals turn to us to bolster supplies of life-saving medical equipment, USME is expanding to give faster service to more hospitals seeking the highest quality medical devices for patients in their care.
We are a medical technology company developing next-generation solutions for the treatment of chronic venous insufficiency, a progressive medical condition affecting an estimated 10% of adults.
BioSig Technologies, Inc. (NASDAQ: BSGM) is a medical device company that is developing a proprietary biomedical signal processing technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Los Angeles-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP™System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig aims to deliver technology to improve upon catheter ablation treatments for the prevalent and potentially deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP™ System is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and has received FDA 510(k) clearance for the PURE EP™ System in August 2018. BioSig Technologies, Inc. is a Nasdaq company: NASDAQ:BSGM.